Table 7.
Comparison of IL-1β, IL-6, and IL-10 Levels of Patients in the Two Groups Before and After Treatment (Pg/Ml)
| Parameters | Before or after treatment | Treatment group (n = 48) |
Placebo group (n = 46) |
|---|---|---|---|
| IL-1β (pg/mL) | Before | 4.97 ± 7.75 | 3.41 ± 3.47 |
| After | 1.92 ± 1.55a | 2.46 ± 2.23a | |
| IL-6 (pg/mL) | Before | 5.30 ± 5.68 | 5.21 ± 5.80 |
| After | 3.11 ± 1.83a | 4.03 ± 3.54 | |
| IL-10 (pg/mL) | Before | 3.89 ± 1.87 | 2.74 ± 1.30b |
| After | 2.37 ± 1.37a | 2.62 ± 1.36 |
Note: aP < 0.05 vs before treatment; bP < 0.05 vs treatment group before treatment, without comparability.